Cargando…
Preclinical Toxicity Evaluation of Clinical Grade Placenta-Derived Decidua Stromal Cells
Placenta-derived decidua stromal cells (DSCs) are being investigated as an alternative to other sources of mesenchymal stromal cells (MSCs) for cellular therapy. DSCs are more effective in treating acute inflammatory diseases in human and this is our preclinical safety study of human DSCs in Sprague...
Autores principales: | Sadeghi, Behnam, Moretti, Gianluca, Arnberg, Fabian, Samén, Erik, Kohein, Bita, Catar, Rusan, Kamhieh-Milz, Julian, Geissler, Sven, Moll, Guido, Holmin, Staffan, Ringdén, Olle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6877599/ https://www.ncbi.nlm.nih.gov/pubmed/31803191 http://dx.doi.org/10.3389/fimmu.2019.02685 |
Ejemplares similares
-
Treatment of radiculomyelopathy in two patients with placenta-derived decidua stromal cells
por: Sadeghi, Behnam, et al.
Publicado: (2019) -
Placenta‐Derived Decidua Stromal Cells for Treatment of Severe Acute Graft‐Versus‐Host Disease
por: Ringden, Olle, et al.
Publicado: (2018) -
Mesenchymal Stromal Cells in Pediatric Hematopoietic Cell Transplantation a Review and a Pilot Study in Children Treated With Decidua Stromal Cells for Acute Graft-versus-Host Disease
por: Ringdén, Olle, et al.
Publicado: (2020) -
Conquering the cytokine storm in COVID‐19‐induced ARDS using placenta‐derived decidua stromal cells
por: Sadeghi, Behnam, et al.
Publicado: (2021) -
Conquering the Cytokine Storm in COVID-19 Induced ARDS Using Placenta-Derived Decidua Stromal Cells
por: Ringden, Olle, et al.
Publicado: (2022)